Assess the Effect of a Whole Fruit Powder on Gut Microbiome Function on Overweight & Obese Adults
NCT06256653 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2024-07-16
Summary
The goal of this clinical trial is to evaluate the effect of freeze-dried blueberry powder on the gut microbiome in overweight and obese adults. The main question\[s\] it aims to answer are:
* Does the supplementation of freeze-dried blueberry powder reduce the risk of obesity or lower the weight of people with a high BMI?
* Does freeze-dried blueberry powder alter the gut microbiome function? Participants will;
* Mix one sachet of Study Product (freeze-dried blueberry powder/placebo) into breakfast/dessert/yoghurt daily for 56 days during the intervention phase.
* Partake in 4 site visits over the 14-week period, including an initial screening visit and a follow-up visit after the intervention phase.
Researchers will compare the effect of freeze-dried blueberry powder with a placebo in a population comprising overweight and obese adults to see if the gut microbiome is altered and if there is a change in body composition.
Conditions
- Obesity
- Overweight and Obesity
Interventions
- DIETARY_SUPPLEMENT
-
Freeze-dried blueberries
* Participants will be supplied with an 8-week supply of Study Product and instructions of dosing. * Participants will be instructed to mix one sachet of the Study Product either to breakfast, or dessert, or mixed with yoghurt daily for the next 56 days, starting on the same day, Day 1. * Additional product will be supplied in case of delay of study visit or loss of Study Product. * Participants will be provided with a stool collection kit and instructions for collecting and storing. Participants will collect stool samples at home, within 48 hours prior to their visit but preferably the morning, of their scheduled visit and bring it to the clinic. * Participants will be provided with a urine collection kit and instructions for collecting and storing.
- DIETARY_SUPPLEMENT
-
Placebo
* Participants will be supplied with an 8-week supply of Placebo Product and instructions of dosing. * Participants will be instructed to mix one sachet of the Placebo Product either to breakfast, or dessert, or mixed with yoghurt daily for the next 56 days, starting on the same day, Day 1. * Additional product will be supplied in case of delay of study visit or loss of Placebo Product. * Participants will be provided with a stool collection kit and instructions for collecting and storing. Participants will collect stool samples at home, within 48 hours prior to their visit but preferably the morning, of their scheduled visit and bring it to the clinic. * Participants will be provided with a urine collection kit and instructions for collecting and storing.
Sponsors & Collaborators
-
U.S. Highbush Blueberry Council
collaborator OTHER -
University College Cork
lead OTHER
Principal Investigators
-
Paul W. O'Toole, Prof. · University College Cork
-
Timothy Dinan, Prof. · Atlantia Clinical Trials
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 50 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-01-29
- Primary Completion
- 2024-09-30
- Completion
- 2025-10-31
Countries
- Ireland
Study Locations
More Related Trials
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of CC-99677 in Healthy Adult Subjects
NCT03554993 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Evaluate the Safety, Tolerability, And Pharmacokinetics Of PF-06266047 In Healthy Adult Subjects
NCT02539550 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 Study of URC102 in Healthy Subjects
NCT01953497 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
NCT03308110 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Effect of Tablet Formulation and Food on PF-07104091 in Healthy Participants
NCT05431153 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability of SPMs in Obese Humans
NCT04701138 ·Status: COMPLETED ·Phase: NA
-
A Study to Investigate Different Formulations of S-337395 in Healthy Adult Participants
NCT06270511 ·Status: COMPLETED ·Phase: PHASE1
-
Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study of PORT-77 Administered to Healthy Adult Participants
NCT06346509 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Drug Exposures Of Two Formulations of PF-02341066
NCT00939731 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic Profiles and Food Effect of CS32582 Capsules
NCT06224595 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Understand the Effect of Tablet Formulation and Food on PF-06821497 in Healthy Adult Participants.
NCT05767905 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Evaluate The Safety And Effects On The Body Of An Investigational Drug Using An Endotoxin-Induced Inflammatory Response Model
NCT01965600 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluation of the Food Effect on the Safety, Tolerability, PK of EC-18 After Oral Administration in Healthy Volunteers
NCT02700360 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Food on the Pharmacokinetics of ORIC-114
NCT06012721 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Clinical Trial in Healthy Male Volunteers
NCT03860532 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Doses of PF-06852231 in Healthy Subjects
NCT03217604 ·Status: COMPLETED ·Phase: PHASE1
-
Single Dose Study to Assess the Safety, Tolerability and Pharmacokinetics(PK) of PF-06865571
NCT03092232 ·Status: COMPLETED ·Phase: PHASE1
-
The Bioavailability of a Spray Dried Dispersion Solid Dose Formulation of PF-06260414 Relative to a Suspension Formulation
NCT02393807 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study to Understand How the Body Processes [14C]PF-07104091 in Healthy Participants
NCT07127770 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Evaluate The Safety, Pharmacokinetics/Pharmacodynamics (PK/PD) and Food Effect Of LC51-0255
NCT03174613 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Pharmacokinetics, Safety & Tolerability of 101-PGC-005 in Healthy, Adult, Human Subjects
NCT05619770 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety and Tolerability of CFTX-1554 in Healthy Subjects
NCT05260658 ·Status: COMPLETED ·Phase: PHASE1
-
A Verification Study to Evaluate the Safety of Long-term Consumption of the Test Food
NCT06715475 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Relative Bioavailability With PF-05089771 Capsule Versus Oral Dispersion
NCT01854996 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Learn About Study Medicine Called PF-07261271 in Healthy People
NCT05536440 ·Status: COMPLETED ·Phase: PHASE1